Rong Xiao Selected Research

Pharmaceutical Preparations

1/2022	Esomeprazole alleviates fibrosis in systemic sclerosis by modulating AhR/Smad2/3 signaling.
1/2020	Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses.
1/2019	A Novel Mutant of rLj-RGD3 (rLj-112) Suppressed the Proliferation and Metastasis of B16 Cells through the EGFR Signaling Pathway.
1/2019	The Anti-tumor Activity and Mechanisms of rLj-RGD3 on Human Laryngeal Squamous Carcinoma Hep2 Cells.
12/2017	rLj-RGD3 Suppresses the Growth of HeyA8 Cells in Nude Mice.
3/2017	rLj-RGD3 induces apoptosis via the mitochondrial-dependent pathway and inhibits adhesion, migration and invasion of human HeyA8 cells via FAK pathway.
1/2016	Levetiracetam might act as an efficacious drug to attenuate cognitive deficits of Alzheimer's disease.
5/2013	Low concentrations of the recombinant toxin protein rLj-RGD3 suppress TNF-α-induced human renal carcinoma cell invasion.
5/2012	Effects of the recombinant toxin protein rLj-RGD3 in multidrug-resistant human breast carcinoma cells.
2/2012	Human retinoblastoma binding protein 9, a serine hydrolase implicated in pancreatic cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rong Xiao Research Topics

Disease

31	Neoplasms (Cancer) 07/2022 - 07/2010
18	Cognitive Dysfunction 02/2022 - 09/2009
17	Alzheimer Disease (Alzheimer's Disease) 04/2022 - 01/2012
13	Inflammation (Inflammations) 12/2022 - 01/2012
12	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 07/2012
10	Burns 06/2013 - 10/2007
8	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2022 - 07/2013
7	Body Weight (Weight, Body) 07/2019 - 05/2009
6	Hypoxia (Hypoxemia) 01/2022 - 09/2008
6	Human Influenza (Influenza) 01/2020 - 02/2004
5	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2012
4	Obesity 06/2022 - 12/2017
4	Skin Diseases (Skin Disease) 02/2022 - 09/2018
4	Fibrosis (Cirrhosis) 01/2022 - 01/2020
4	COVID-19 10/2021 - 11/2020
4	Choriocarcinoma 01/2021 - 01/2006
4	Hypercholesterolemia 01/2020 - 01/2016
4	Infections 01/2019 - 02/2004
4	Lymphoma (Lymphomas) 08/2018 - 04/2012
3	Carcinogenesis 01/2022 - 09/2018
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 06/2018
3	Vitiligo 01/2022 - 03/2014
3	Neoplasm Metastasis (Metastasis) 12/2021 - 05/2013
3	Colorectal Neoplasms (Colorectal Cancer) 12/2021 - 07/2019
3	Ovarian Neoplasms (Ovarian Cancer) 10/2021 - 06/2017
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020 - 12/2012
3	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 12/2003
3	Glioma (Gliomas) 01/2017 - 07/2013
3	Chromosome Aberrations (Chromosome Abnormalities) 10/2016 - 04/2004
3	Wounds and Injuries (Trauma) 01/2013 - 06/2009
2	Overweight 02/2022 - 12/2019
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 12/2016
2	Rupture 01/2022 - 10/2002
2	Hypertension (High Blood Pressure) 01/2022 - 12/2021
2	Vitamin D Deficiency 12/2021 - 01/2021
2	Hypersensitivity (Allergy) 01/2021 - 01/2013
2	Birth Weight (Birth Weights) 01/2021 - 05/2020
2	Dermatomyositis (Dermatopolymyositis) 11/2020 - 10/2019
2	Dermatitis 10/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

32	Proteins (Proteins, Gene)FDA Link 02/2022 - 02/2004
15	CholesterolIBA 04/2022 - 04/2015
10	Pharmaceutical PreparationsIBA 01/2022 - 02/2012
9	Peptides (Polypeptides)IBA 01/2022 - 10/2012
8	OxysterolsIBA 04/2022 - 10/2016
8	CytokinesIBA 01/2022 - 09/2008
7	27-hydroxycholesterolIBA 04/2022 - 01/2017
7	EnzymesIBA 10/2019 - 03/2006
7	SolutionsIBA 12/2014 - 06/2008
6	LipidsIBA 06/2022 - 06/2009
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 10/2010
5	Amyloid (Amyloid Fibrils)IBA 01/2022 - 07/2013
5	LigandsIBA 01/2022 - 11/2013
5	Antiviral Agents (Antivirals)IBA 10/2021 - 09/2008
5	Messenger RNA (mRNA)IBA 01/2019 - 11/2008
5	GenisteinIBA 10/2016 - 09/2009
5	Enalaprilat (Vasotec)FDA LinkGeneric 01/2012 - 10/2007
4	Fatty Acids (Saturated Fatty Acids)IBA 06/2022 - 02/2021
4	AutoantibodiesIBA 01/2022 - 05/2013
4	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2021 - 01/2012
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 06/2010
4	Biological ProductsIBA 12/2014 - 09/2011
4	salicylhydroxamic acid (SHAM)IBA 07/2012 - 12/2008
4	HLA-G Antigens (HLA G)IBA 11/2008 - 01/2006
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2019
3	CreatinineIBA 01/2022 - 07/2012
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2018
3	TeaIBA 12/2021 - 06/2009
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2021 - 11/2004
3	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2016
3	Long Noncoding RNAIBA 01/2020 - 06/2017
3	Folic Acid (Vitamin M)FDA LinkGeneric 10/2019 - 11/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2019 - 07/2016
3	IntegrinsIBA 01/2019 - 05/2012
3	Sirolimus (Rapamycin)FDA Link 01/2019 - 09/2008
3	IsoflavonesIBA 01/2018 - 11/2004
3	AntioxidantsIBA 02/2016 - 06/2009
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2014 - 01/2012
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2022 - 09/2008
2	Monounsaturated Fatty AcidsIBA 02/2022 - 01/2022
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2022 - 02/2021
2	Interleukin-18 (Interleukin 18)IBA 01/2022 - 06/2010
2	OccludinIBA 01/2022 - 06/2020
2	IsoenzymesIBA 06/2021 - 07/2012
2	Angiotensin IIIBA 06/2021 - 07/2012
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2018
2	HDL CholesterolIBA 01/2021 - 05/2020
2	InterferonsIBA 01/2021 - 01/2019
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 11/2020 - 10/2020
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2020 - 12/2018
2	Interleukin-10 (Interleukin 10)IBA 06/2020 - 09/2008
2	CD40 Ligand (CD40L)IBA 01/2020 - 07/2012
2	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2019 - 10/2010
2	NF-kappa B (NF-kB)IBA 01/2019 - 06/2010
2	AcidsIBA 01/2019 - 09/2011

Therapy/Procedure

17	Therapeutics 02/2022 - 08/2010
5	Drug Therapy (Chemotherapy) 12/2021 - 12/2012
3	Resuscitation 06/2013 - 02/2004
2	Oral Administration 01/2021 - 08/2012
2	Photochemotherapy (Photodynamic Therapy) 09/2020 - 12/2018